Bulk drug classification under residuary tariff item triggered unconditional exemption despite original misclassification claim.

A bulk drug imported in powder form did not satisfy the additional naming and publication conditions for patent or proprietary medicines, so it was not classifiable under Tariff Item 14E and fell under the residuary Tariff Item 68. Once classified under Tariff Item 68, the unconditional exemption in Notification No. 234/82-C.E. applied to bulk drugs, medicines and drug-intermediates not elsewhere specified, and the exemption could not be denied merely because the importer had originally claimed a different classification. The relief also extended to the refund consequence indicated in the text without requiring a fresh claim in the circumstances described.

---

---

Issues: (i) Whether TPP Powder, imported as a bulk drug, was classifiable under Tariff Item 14E as patent or proprietary medicines or under the residuary Tariff Item 68. (ii) Whether, if classifiable under Tariff Item 68, the goods were entitled to exemption under Notification No. 234/82-C.E. dated 01-11-1982.

Issue (i): Whether TPP Powder, imported as a bulk drug, was classifiable under Tariff Item 14E as patent or proprietary medicines or under the residuary Tariff Item 68.

Analysis: Classification under Tariff Item 14E required not only that the product be a drug or medicinal preparation used for treatment or prevention of ailments, but also that it satisfy the further requirements in the Explanation, including the prescribed naming and publication conditions. A bulk drug imported in powder form could not meet those additional requirements. The product therefore did not answer the description of patent or proprietary medicines.

Conclusion: The goods were not classifiable under Tariff Item 14E and were correctly classified under Tariff Item 68.

Issue (ii): Whether, if classifiable under Tariff Item 68, the goods were entitled to exemption under Notification No. 234/82-C.E. dated 01-11-1982.

Analysis: The notification was unconditional and covered bulk drugs, medicines and drug-intermediates not elsewhere specified. Once the Revenue's stand that the goods fell under Tariff Item 68 was accepted, the consequence of that classification was availability of the exemption. The benefit could not be denied merely because the assessee had originally claimed classification under Tariff Item 14E. The refund consequence under the customs refund provision also supported grant of relief without a fresh claim in the circumstances.

Conclusion: The goods were entitled to exemption under Notification No. 234/82-C.E. dated 01-11-1982.

Final Conclusion: The appeal succeeded on the exemption issue while the classification under Tariff Item 68 was sustained, resulting in relief to the importer.

Ratio Decidendi: A bulk drug in powder form that does not satisfy the additional naming and publication conditions in the definition of patent or proprietary medicines is classifiable under the residuary tariff item, and an unconditional exemption applicable to such goods cannot be denied merely because a different classification had originally been claimed.

---